Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009
Author:
Affiliation:
1. Department of Leukemia and Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center and Texas Children Hospital, Houston, TX, USA
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.745525
Reference44 articles.
1. Cancer Statistics, 2010
2. BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia
3. Chronic myeloid leukaemia
4. Imatinib Mesylate — The New Gold Standard for Treatment of Chronic Myeloid Leukemia
5. Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial;Leukemia;2024-01-26
2. Disparity in hematological malignancies: From patients to health care professionals;Blood Reviews;2024-01
3. Assessment of knowledge, attitudes, and practices of CML patients and their families toward TKI therapy in China;Medicine;2023-12-15
4. Spontaneous Remission in a Patient with Chronic Myeloid Leukemia: A Case Report;Case Reports in Oncology;2023-10-06
5. Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series;Cureus;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3